• FaceMind

  Led · Seed · Aug 2026

  FaceMind is focused on building "world models," AI systems intended to model and simulate the physical world. The company was launched by researcher Hongyuan Lu shortly after he completed his doctorate in AI and engineering about a year prior to the raise. FaceMind is based in Shanghai and Hong Kong. Its technology is positioned for potential applications in robotics, autonomous vehicles and industrial simulation, areas highlighted in coverage of the startup. Financially, FaceMind has just closed a $20 million seed round with participation from Qihoo 360's venture fund. The article does not report revenue, users, valuation, or detailed product milestones.

• Silicon Flow

  Participated · Seed · Jul 2024

  Over the past year Silicon Mobile Technology has achieved explosive growth in the enterprise market, operating a Token-factory model to deliver efficient MaaS (model-as-a-service). The company reports daily token call volumes reaching tens of trillions and serves more than 10 million users and over 10,000 enterprise customers. Its revenue grew by more than 10x year-over-year, and its overseas business reached monthly revenues in the hundreds of thousands of U.S. dollars. The firm positions itself across the energy, chip, compute infrastructure, cloud services, large-model and scenario-application ecosystem and has attracted investment from leaders across those segments. The announcement did not disclose founding year or headquarters location.

• Holaverse

  Participated · Equity · Apr 2016

  Holaverse develops Android consumer apps including a mobile games platform and several utility apps. Its product suite includes Hola Games, Hola Launcher, Locker Master and Omni Swipe. The company is led by CEO Brian Xie and is based in Shangai, China. Holaverse closed a $70M funding round and plans to deploy proceeds toward corporate team-building, product R&D and global expansion. Management intends to develop and roll out new and original products for its global mobile game platform and expand into social networking. No operating metrics were disclosed in the article.

• Silk Labs

  Participated · Equity · Feb 2016

  Silk Labs is developing Sense, an intelligent smart-home hub that learns from residents’ behavior to automate lights, thermostats, music and security alerts. Sense uses on-device machine learning and computer vision (facial recognition), along with Bluetooth LE, voice, gestures and a companion app for interaction. Out of the box it integrates with Philips Hue, LIFX, Nest and Sonos, with additional integrations planned. The company emphasizes privacy by performing all core ML and data processing on the device and only sending encrypted clips to the cloud; decryption keys remain on the device. Silk Labs has a 13-person team based in San Mateo and is led by co-founder and CEO Andreas Gal; co-founders include Chris Jones and Michael Vines. Financially, the company is backed by $2.5 million in funding and is launching Sense via a Kickstarter campaign with early-bird pre-orders at $225 and shipping later this year.

• Profusa

  Participated · Series B · Dec 2015

  Profusa develops bioengineered, tissue-integrating biosensors that become one with the body to detect and continuously transmit medical-grade data of body chemistry for personal and medical use. Its first clinical offering, the Profusa Lumee™ Oxygen Platform, is CE Marked for use in the European Union and is designed to report reliable tissue oxygen levels both acutely and long-term. Potential applications cited include monitoring compromised tissue such as peripheral artery disease, chronic wounds like diabetic ulcers and pressure sores, sleep apnea, COPD, and reconstructive surgery. The company intends to use the Series C proceeds to advance commercialization of the Lumee Oxygen Platform and to accelerate development of its glucose biosensor technology. Profusa is led by chairman and CEO Ben Hwang, Ph.D. The financing strengthens the company's ability to move toward broader market adoption and further product development. Profusa develops biologically integrated, implanted biosensors for long-term, continuous monitoring of body chemistry to improve personal health and manage disease. Its first product, the Lumee Oxygen Sensing System™, measures tissue-oxygen perfusion and is slated to be available in Europe in early 2016 for clinical management of chronic wounds. The company intends to use recent funding to advance development and commercialization of its technology. Profusa is led by chairman and CEO Ben Hwang, Ph.D., and was founded in 2009 in South San Francisco, CA. In conjunction with the Series B, Karen Liu of 3E Bioventures and Joan Braddi of Google joined Profusa’s board. To date the company has raised more than $30M in funding.

No current team members are available.